1. Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer
   María Cámara-Quílez et al, 2020, Current Medicinal Chemistry CrossRef
2. HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
   Xing Guo et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
3. IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development
   Lei Lv et al, 2024, Cellular & Molecular Biology Letters CrossRef
4. microRNAs‐107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1
   Hongyan Ai et al, 2019, Journal of Cellular Biochemistry CrossRef
5. Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis
   Christian Bailly et al, 2020, Life Sciences CrossRef
6. HMGB1 as a therapeutic target in disease
   Jiaming Xue et al, 2021, Journal of Cellular Physiology CrossRef
7. Biological functions and theranostic potential of HMGB family members in human cancers
   Liaoran Niu et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
8. Celastrol induces premature ovarian insufficiency by inducing apoptosis in granulosa cells
   Fan Wen et al, 2023, Biomedicine & Pharmacotherapy CrossRef
9. Necrosis of osteosarcoma cells induces the production and release of high‑mobility group box 1 protein
   Jiyu Yang et al, 2017, Experimental and Therapeutic Medicine CrossRef
10. HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer
    Kim Jun Cheng et al, 2020, Cellular Oncology CrossRef
11. Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting
    Lu Li et al, 2021, Frontiers in Pharmacology CrossRef